Financial Highlights
Operating Results and Financial Position (annual)
During the fiscal year ended March 31, 2026, revenue decreased 38,122 million yen (5.3%) year on year to 677,163 million yen. Operating loss was 112,448 million yen (compared with operating profit of 2,422 million yen in the previous fiscal year), loss before tax was 106,511 million yen (compared with profit before tax of 4,533 million yen in the previous fiscal year), and loss attributable to owners of parent was 86,088 million yen (compared with profit attributable to owners of parent of 6,123 million yen in the previous fiscal year). Performance by segment is shown below the graph.
Imaging Products Business
Sales were led by NIKON's first digital cinema camera, the ZR. However, the business segment recorded year-on-year decreases in both revenue and profit, reflecting a decline in average selling prices due to changes in the product mix and higher promotion expenses amid an intensifying competitive environment, as well as tariff impacts and one-time costs related to the share transfer agreement for Mark Roberts Motion Control Limited, among other factors.
As a result, this business segment recorded revenue of 290,053 million yen (down 1.8% year on year) and operating profit of 16,715 million yen (down 59.5% year on year).
Precision Equipment Business
Unit sales of systems in the FPD lithography systems field and unit sales of ArF dry and immersion lithography systems in the semiconductor lithography system field decreased.
As a result, this business segment as a whole recorded year-on-year decreases in both revenue and profit. Consequently, this business segment recorded revenue of 167,258 million yen (down 17.2% year on year) and operating loss of 4,565 million yen (compared with operating profit of 1,544 million yen in the previous fiscal year).
Healthcare Business
The eye care solutions field remained firm, mainly in Europe and the United States, resulting in an increase in revenue, and the contract cell development and manufacturing field continued to perform strongly from the previous fiscal year. However, the life science solutions field was adversely affected by sluggish market conditions in the United States and tariff impacts. In addition, profit in the eye care solutions field was also pressured by tariff impacts and increased recording of provisions for certain transactions.
As a result, this business segment as a whole recorded year-on-year decreases in both revenue and profit. Consequently, this business segment recorded revenue of 111,922 million yen (down 3.9% year on year) and operating profit of 1,561 million yen (down 76.8% year on year).
Components Business
The Industrial Solutions Business recorded robust sales of Video Measuring Systems for electronic components and semiconductors, among other products. Partly reflecting the effects of structural reforms related to the Industrial Metrology Business and improved profitability resulting from changes in the product mix, the Industrial Solutions Business recorded year-on-year increases in both revenue and profit.
The Customized Products Business recorded year-on-year decreases in both revenue and profit as sales of EUV-related components were adversely affected by a slowdown in the EUV-related markets.
As a result, this business segment recorded revenue of 76,176 million yen (up 2.8% year on year) and operating profit of 9,553 million yen (up 33.0% year on year).
Digital Manufacturing Business
The Group recorded a year-on-year increase in revenue due to an increase in unit sales of large-size equipment and the positive effects of foreign exchange movements. However, the Group recorded impairment losses on non-financial assets, among other factors, resulting in a wider operating loss.
As a result, this business segment recorded revenue of 28,090 million yen (up 20.3% year on year) and operating loss of 106,282 million yen (compared with operating loss of 15,225 million yen in the previous fiscal year).
